AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionCrescent Grove Advisors, LLC
Latest Disclosed Ownership4,873 shares
Latest Disclosed Value $ 1,059,829
Crescent Grove Advisors, LLC ownership in 4AB / AbbVie Inc.

On May 6, 2026 - Crescent Grove Advisors, LLC filed a 13F-HR form disclosing ownership of 4,873 shares of AbbVie Inc. (BG:4AB) valued at $1,059,829 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 4,873 shares of AbbVie Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F Abbvie Inc Com COMM 00287Y109 4,873 0 0.00 1,060 -4.85 0.1000
2026-02-10 2025-12-31 13F Abbvie Inc Com COMM 00287Y109 4,873 -16 -0.33 1,113 -1.59 0.1033
2025-11-13 2025-09-30 13F Abbvie Inc Com COMM 00287Y109 4,889 -581 -10.62 1,132 11.43 0.1074
2025-08-13 2025-06-30 13F Abbvie Inc Com COMM 00287Y109 5,470 -1,667 -23.36 1,015 -32.11 0.0984
2025-04-24 2025-03-31 13F Abbvie Inc Com COMM 00287Y109 7,137 -553 -7.19 1,495 9.44 0.1558
2025-01-21 2024-12-31 13F Abbvie Inc Com COMM 00287Y109 7,690 2,696 53.98 1,367 38.54 0.1355
2024-10-30 2024-09-30 13F Abbvie Inc Com COMM 00287Y109 4,994 -544 -9.82 986 3.90 0.1006
2024-07-22 2024-06-30 13F Abbvie Inc Com COMM 00287Y109 5,538 -2,425 -30.45 950 -34.55 0.1041
2024-04-29 2024-03-31 13F Abbvie Inc Com COMM 00287Y109 7,963 -200 -2.45 1,450 14.62 0.1512
2024-01-30 2023-12-31 13F Abbvie Inc Com COMM 00287Y109 8,163 -248 -2.95 1,265 0.96 0.1410
2023-10-25 2023-09-30 13F Abbvie Inc Com COMM 00287Y109 8,411 -2,951 -25.97 1,254 -18.10 0.1562
2023-07-13 2023-06-30 13F Abbvie Inc Com COMM 00287Y109 11,362 4,670 69.78 1,531 43.53 0.1643
2023-05-03 2023-03-31 13F Abbvie Inc Com COMM 00287Y109 6,692 -3,893 -36.78 1,067 -37.66 0.1238
2023-01-12 2022-12-31 13F Abbvie Inc Com COMM 00287Y109 10,585 170 1.63 1,711 22.32 0.1779
2022-11-08 2022-09-30 13F Abbvie Inc Com COMM 00287Y109 10,415 6,639 175.82 1,398 141.87 0.1615
2022-07-20 2022-06-30 13F Abbvie Inc Com COMM 00287Y109 3,776 -3,110 -45.16 578 -48.21 0.0608
2022-05-04 2022-03-31 13F Abbvie Inc Com COMM 00287Y109 6,886 -74 -1.06 1,116 18.47 0.1093
2022-01-24 2021-12-31 13F Abbvie Inc Com COMM 00287Y109 6,960 -718 -9.35 942 13.77 0.0884
2021-10-26 2021-09-30 13F Abbvie Inc Com COMM 00287Y109 7,678 3,854 100.78 828 92.11 0.0880
2021-07-26 2021-06-30 13F Abbvie Inc Com COMM 00287Y109 3,824 -820 -17.66 431 -14.31 0.0453
2021-05-07 2021-03-31 13F Abbvie Inc Com COMM 00287Y109 4,644 1,341 40.60 503 42.09 0.0589
2021-02-01 2020-12-31 13F Abbvie Inc Com COMM 00287Y109 3,303 365 12.42 354 37.74 0.0463
2020-11-06 2020-09-30 13F Abbvie Inc Com COMM 00287Y109 2,938 -5 -0.17 257 -11.07 0.0512
2020-08-03 2020-06-30 13F Abbvie Inc Com COMM 00287Y109 2,943 0 0.00 289 29.02 0.0611
2020-04-27 2020-03-31 13F Abbvie Inc Com COMM 00287Y109 2,943 78 2.72 224 -11.81 0.0498
2020-02-03 2019-12-31 13F Abbvie Inc Com COMM 00287Y109 2,865 -2,000 -41.11 254 -30.98 0.0441
2019-10-31 2019-09-30 13F Abbvie Inc Com COMM 00287Y109 4,865 0 0.00 368 3.95 0.0706
2019-08-06 2019-06-30 13F Abbvie Inc Com COMM 00287Y109 4,865 -5,278 -52.04 354 -56.67 0.0667
2019-05-13 2019-03-31 13F Abbvie Inc Com COMM 00287Y109 10,143 3,100 44.02 817 25.89 0.1675
2019-01-29 2018-12-31 13F Abbvie Inc Com COMM 00287Y109 7,043 -5,134 -42.16 649 -43.66 0.1384
2018-11-05 2018-09-30 13F Abbvie Inc Com COMM 00287Y109 12,177 220 1.84 1,152 3.97 0.2489
2018-07-16 2018-06-30 13F Abbvie Inc Com COMM 00287Y109 11,957 -500 -4.01 1,108 -6.02 0.2748
2018-05-03 2018-03-31 13F Abbvie Inc Com COMM 00287Y109 12,457 500 4.18 1,179 1.99 0.2890
2018-02-06 2017-12-31 13F Abbvie Inc Com COMM 00287Y109 11,957 0 0.00 1,156 8.85 0.2905
2017-11-06 2017-09-30 13F Abbvie Inc Com COMM 00287Y109 11,957 0 0.00 1,062 22.49 0.2724
2017-08-02 2017-06-30 13F Abbvie Inc Com COMM 00287Y109 11,957 11,957 867 0.2500
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.